SBC Medical Q2FY26 Results: Revenue up 13%, operating profit rises 30%
- Revenue rose 13% YoY to $49.2 million in Q2FY26, aided by Waqoo acquisition
- Operating profit surged 30% YoY, while gross profit jumped to $36.0 million
- Cash reserves stand at $185 million against $38 million in total debt
- Management projects up to $15 million in additional revenue from AI initiatives
*this image is generated using AI for illustrative purposes only.
SBC Medical Group Holdings Incorporated (NASDAQ: SBC) reported a recovery in its second quarter of fiscal year 2026, driven by franchise fee normalization and the inclusion of acquired Waqoo operations. The company, which manages cosmetic treatment centers across Asia and the US, posted strong top-line and bottom-line growth.
Financial Performance
Revenue for Q2FY26 reached $49.2 million, marking a 13% increase year-over-year. This growth reflects the reversal of the 2025 franchising fee reduction and the consolidation of Waqoo’s financials. Sequentially, revenue grew approximately 14% from the previous quarter.
Profitability metrics improved significantly alongside the revenue expansion. Operating profit rose 30% year-over-year. Gross profit expanded to $36.0 million from $30.0 million in the prior-year period, indicating an improvement in margin structure as higher-margin services or operational efficiencies took effect.
| Metric | Q2FY26 | Q2FY25 (Implied) | Change |
|---|---|---|---|
| Revenue | $49.2 million | ~$43.5 million | +13% YoY |
| Gross Profit | $36.0 million | $30.0 million | +$6.0 million |
| Operating Profit | Not Disclosed | Not Disclosed | +30% YoY |
Balance Sheet Strength
The company maintains a robust liquidity position. SBC ended the quarter with $185 million in cash on its balance sheet. Against this stands total debt of just $38 million. The source notes a Debt/Book Equity ratio of 14%, highlighting a low-leverage profile that provides flexibility for future acquisitions or capital expenditures.
Strategic Initiatives
Management outlined several growth vectors for the remainder of the fiscal year:
- AI Integration: The company expects AI-driven initiatives at the clinic level in H2FY26 to contribute up to $15 million in additional revenue. These efforts aim to enhance customer experience and operational efficiency.
- Global Expansion: SBC continues to broaden its international footprint through acquisitions and partnerships. Recent moves include the acquisition of AHH in Singapore, a partnership with BLEZ ASIA in Thailand, and an equity investment in Orange Twist in the United States.
- Clinic Network: In Japan, the core market, the company now operates 287 clinics.
What the Numbers Show
The divergence between gross profit growth ($6.0 million increase) and operating profit growth (30% increase) suggests that operating leverage is improving. While gross profit rose by 20%, operating profit grew faster, implying that fixed costs were better absorbed by the higher revenue base or that administrative expenses were controlled relative to sales growth. Additionally, the cash position ($185 million) is nearly five times the total debt ($38 million), providing a significant buffer against market volatility.
Market Context
SBC has taken steps to improve trading liquidity, including becoming a Russell 3000 component and partially reducing founder ownership concentration. This research update was issued by Emerging Growth Research, LLC, a firm that provides company-sponsored research services.
How will the integration of Waqoo and AHH operations impact SBC's long-term operating margins and synergies?
What specific KPIs will management use to measure the success of the AI-driven initiatives expected to generate $15 million in H2FY26?
Given the low debt-to-equity ratio, does SBC have a defined strategy for deploying its $185 million cash reserve toward M&A or share buybacks?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
